BIOMAT Database Logo BIOMAT Database Logo

Acetylene compounds of potential pharmacological value. XXIII. N-(1-Methyl-5-pyrrolidino-3-pentynyl)-substituted succinimide and 2-pyrrolidone. 1975

S Lindgren, and U Svensson, and R Dahlbom

UI MeSH Term Description Entries
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013388 Succinimides A subclass of IMIDES with the general structure of pyrrolidinedione. They are prepared by the distillation of ammonium succinate. They are sweet-tasting compounds that are used as chemical intermediates and plant growth stimulants. Butanimides,Pyrrolidinediones
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. XXX. Synthesis and pharmacological properties of N-(4-pyrrolidino-2-pentynyl)-substituted 2-pyrrolidone and succinimide.
January 1979, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.
January 1978, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.
January 1979, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. 13. 2-substituted 1,3-indandiones.
June 1969, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. 8. N-(4-dialkylamino-2-butynyl)-substituted cyclic imides.
November 1966, Journal of medicinal chemistry,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
January 1975, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. IX. N-(4-dialkylamino-2-butynyl)-substituted carboxylic and sulphonic acid amides.
September 1967, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. XXXVI. N-(4-tert-Amino-2-butynyl)-substituted 2(3H)-thiazolones and 2(3H)-oxazolones.
January 1978, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.
April 1972, Acta pharmaceutica Suecica,
S Lindgren, and U Svensson, and R Dahlbom
Acetylene compounds of potential pharmacological value. XL. N-(tert-aminoalkynyl)-substituted 3-isothiazolidinone-1,1-dioxides and tetrahydro-1,2-thiazin-3-one-1,1-dioxides.
January 1987, Acta pharmaceutica Suecica,
Copied contents to your clipboard!